Background and aims: Type I hyperlipoproteinemia is an autosomal recessive disorder of lipoprotein metabolism caused by mutations in the LPL gene, with an estimated prevalence in the general population of 1 in a million. In this work, we studied the molecular mechanism of two known mutations in the LPL gene in ex vivo and in vitro experiments and also the effect of two splice site mutations in ex vivo experiments. Methods: Two patients with hypertriglyceridemia were selected from the Lipid Clinic in Vienna. The first patient was compound heterozygote for c.680T > C (exon 5; p.V200A) and c.1139+1G > A (intron 7 splice site). The second patient was compound heterozygote for c.953A > G (exon 6; p.N291S) and c.1019-3C > A (intron 6 splice site). The LPL gene was sequenced and post-heparin plasma samples (ex vivo) were used to test LPL activity. In vitro experiments were performed in HEK 293T/17 cells transiently transfected with wild type or mutant LPL plas- mids. Cell lysate and media were used to evaluate LPL production, secretion, activity and dimerization by Western blot analysis and LPL enzymatic assay, respectively. Results: Our data show that in both patients, LPL activity is absent. V200A is a mutation that alters LPL secretion and activity whereas the N291S mutation affects LPL activity, but both mutations do not affect dimerization. The effect of these mutations in patients is more severe since they have splice site mutations on the other allele. Conclusions: We characterized these LPL mutations at the molecular level showing that are pathogenic.
Deciphering the role of V200A and N291S mutations leading to LPL deficiency / M. Botta, E. Maurer, M. Ruscica, S. Romeo, T.M. Stulnig, P. Pingitore. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 282(2019 Mar), pp. 45-51.
|Titolo:||Deciphering the role of V200A and N291S mutations leading to LPL deficiency|
BOTTA, MARGHERITA [Writing – Original Draft Preparation]
RUSCICA, MASSIMILIANO [Writing – Review & Editing]
|Parole Chiave:||Familial hypertrygliceridemia, Lipase deficiency, Missense and frameshift mutations, Lipoprotein lipase, rs528243561, rs767260655, rs268, cs941507|
|Settore Scientifico Disciplinare:||Settore MED/04 - Patologia Generale|
Settore BIO/14 - Farmacologia
|Data di pubblicazione:||mar-2019|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.atherosclerosis.2019.01.004|
|Appare nelle tipologie:||01 - Articolo su periodico|